Literature DB >> 24001772

The membrane-proximal KXGFFKR motif of α-integrin mediates chemoresistance.

Chi-Chao Liu1, Pascal Leclair, Shyong Quin Yap, Chinten James Lim.   

Abstract

Cell adhesion-mediated drug resistance contributes to minimal residual disease and relapse in hematological malignancies. Here, we show that adhesion of Jurkat T-acute lymphoblastic leukemia cells to substrates engaging α4β1-integrin or α5β1-integrin promotes chemoresistance to doxorubicin-induced apoptosis. Reconstituted expression of α4δ, a truncated α4-integrin with KXGFFKR as the cytoplasmic motif, in α4-deficient cells promoted chemoresistance to doxorubicin in a manner independent of α4-mediated adhesion. The adhesion-independent chemoresistance did not require β1-integrin as the heterodimeric pair, since expression of Tacδ, a monomeric nonintegrin transmembrane protein fused to the juxtamembrane KXGFFKR, was sufficient to reproduce the phenomenon. The requirement for integrin-mediated adhesion in stimulation of Akt phosphorylation and activation was bypassed for cells expressing α4δ and Tacδ. Cells expressing α4δ and Tacδ exhibited a high influx of extracellular Ca(2+), and inhibition of Ca(2+) channels with verapamil attenuated the adhesion-independent chemoresistance. Tacδ cells also exhibited greater rates of drug efflux. α4δ and Tacδ interacted with the Ca(2+)-binding protein calreticulin, in a manner dependent on the KXGFFKR motif. Adhesion-mediated engagement of α4-integrins promoted an increased calreticulin-α4 association and greater influx of extracellular Ca(2+) than in nonadherent cells. The α-integrin KXGFFKR motif is involved in adhesion-mediated control of chemoresistance in T cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24001772      PMCID: PMC3811891          DOI: 10.1128/MCB.00580-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

1.  The binding of Mss4 to alpha-integrin subunits regulates matrix metalloproteinase activation and fibronectin remodeling.

Authors:  Alexander Knoblauch; Carola Will; Grigori Goncharenko; Stephan Ludwig; Viktor Wixler
Journal:  FASEB J       Date:  2006-12-16       Impact factor: 5.191

Review 2.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

Review 3.  Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation.

Authors:  Cindy Q Xia; Peter G Smith
Journal:  Mol Pharmacol       Date:  2012-07-23       Impact factor: 4.436

4.  Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.

Authors:  W G King; M D Mattaliano; T O Chan; P N Tsichlis; J S Brugge
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  Thrombospondin mediates focal adhesion disassembly through interactions with cell surface calreticulin.

Authors:  S Goicoechea; A W Orr; M A Pallero; P Eggleton; J E Murphy-Ullrich
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

Review 6.  Acute myeloid leukaemia.

Authors:  Elihu Estey; Hartmut Döhner
Journal:  Lancet       Date:  2006-11-25       Impact factor: 79.321

7.  A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells.

Authors:  Fabienne De Toni-Costes; Mathieu Despeaux; Jessica Bertrand; Ezzeddine Bourogaa; Loïc Ysebaert; Bernard Payrastre; Claire Racaud-Sultan
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

Review 8.  The ins and outs of leukocyte integrin signaling.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Changes in endoplasmic reticulum luminal environment affect cell sensitivity to apoptosis.

Authors:  K Nakamura; E Bossy-Wetzel; K Burns; M P Fadel; M Lozyk; I S Goping; M Opas; R C Bleackley; D R Green; M Michalak
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

10.  Xenopus embryonic cell adhesion to fibronectin: position-specific activation of RGD/synergy site-dependent migratory behavior at gastrulation.

Authors:  J W Ramos; D W DeSimone
Journal:  J Cell Biol       Date:  1996-07       Impact factor: 10.539

View more
  16 in total

Review 1.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

2.  Cancer Biology of the Endoplasmic Reticulum Lectin Chaperones Calreticulin, Calnexin and PDIA3/ERp57.

Authors:  Shing Tat Theodore Lam; Chinten James Lim
Journal:  Prog Mol Subcell Biol       Date:  2021

3.  New Abelson interactor-1 (Abi-1)-driven mechanism of acquired drug resistance.

Authors:  A Chorzalska; P M Dubielecka
Journal:  Leuk Suppl       Date:  2014-12-17

4.  Dermal fibroblasts promote cancer cell proliferation and exhibit fibronectin overexpression in early mycosis fungoides.

Authors:  Burcu Beksaç; Laura Gleason; Sarah Baik; John M Ringe; Pierluigi Porcu; Neda Nikbakht
Journal:  J Dermatol Sci       Date:  2022-03-14       Impact factor: 5.408

Review 5.  Role of integrin alpha4 in drug resistance of leukemia.

Authors:  Stephanie Shishido; Halvard Bönig; Yong-Mi Kim
Journal:  Front Oncol       Date:  2014-05-23       Impact factor: 6.244

6.  The Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell Death.

Authors:  Meriem Bachsais; Nadim Naddaf; Daniel Yacoub; Suzanne Salti; Nada Alaaeddine; Fawzi Aoudjit; Ghada S Hassan; Walid Mourad
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

7.  Endoplasmic reticulum in health and disease: the 12th International Calreticulin Workshop, Delphi, Greece.

Authors:  Aristidis S Charonis; Marek Michalak; Jody Groenendyk; Luis B Agellon
Journal:  J Cell Mol Med       Date:  2017-11-21       Impact factor: 5.310

Review 8.  β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer.

Authors:  Anne-Florence Blandin; Guillaume Renner; Maxime Lehmann; Isabelle Lelong-Rebel; Sophie Martin; Monique Dontenwill
Journal:  Front Pharmacol       Date:  2015-11-24       Impact factor: 5.810

9.  α-Integrin expression and function modulates presentation of cell surface calreticulin.

Authors:  C-C Liu; P Leclair; M Monajemi; L M Sly; G S Reid; C J Lim
Journal:  Cell Death Dis       Date:  2016-06-16       Impact factor: 8.469

10.  Dual Targeting of Stromal Cell Support and Leukemic Cell Growth by a Peptidic PKC Inhibitor Shows Effectiveness against B-ALL.

Authors:  Paola Fernanda Ruiz-Aparicio; Natalia-Del Pilar Vanegas; Gloria Inés Uribe; Paola Ortiz-Montero; Camila Cadavid-Cortés; Jimmy Lagos; Jessica Flechas-Afanador; Adriana Linares-Ballesteros; Jean-Paul Vernot
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.